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MEDICAL IMAGING

Performance of deep learning synthetic CTs for MR‐only brain
radiation therapy
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Abstract
Purpose: To evaluate the dosimetric and image‐guided radiation therapy (IGRT) per-
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formance of a novel generative adversarial network (GAN) generated synthetic CT
(synCT) in the brain and compare its performance for clinical use including conventional
brain radiotherapy, cranial stereotactic radiosurgery (SRS), planar, and volumetric IGRT.
Methods and Materials: SynCT images for 12 brain cancer patients (6 SRS, 6 conventional) were generated from T1‐weighted postgadolinium magnetic resonance
(MR) images by applying a GAN model with a residual network (ResNet) generator
and a convolutional neural network (CNN) with 5 convolutional layers as the discriminator that classiﬁed input images as real or synthetic. Following rigid registration, clinical structures and treatment plans derived from simulation CT (simCT)
images were transferred to synCTs. Dose was recalculated for 15 simCT/synCT plan
pairs using ﬁxed monitor units. Two‐dimensional (2D) gamma analysis (2%/2 mm,
1%/1 mm) was performed to compare dose distributions at isocenter. Dose–volume
histogram (DVH) metrics (D95%, D99%, D0.2cc, and D0.035cc) were assessed for the tar-
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gets and organ at risks (OARs). IGRT performance was evaluated via volumetric registration between cone beam CT (CBCT) to synCT/simCT and planar registration
between KV images to synCT/simCT digital reconstructed radiographs (DRRs).
Results: Average gamma passing rates at 1%/1mm and 2%/2mm were 99.0 ± 1.5%
and 99.9 ± 0.2%, respectively. Excellent agreement in DVH metrics was observed
(mean difference ≤0.10 ± 0.04 Gy for targets, 0.13 ± 0.04 Gy for OARs). The population averaged mean difference in CBCT‐synCT registrations were <0.2 mm and 0.1
degree different from simCT‐based registrations. The mean difference between kV‐
synCT DRR and kV‐simCT DRR registrations was <0.5 mm with no statistically signiﬁcant differences observed (P > 0.05). An outlier with a large resection cavity exhibited
the worst‐case scenario.
Conclusion: Brain GAN synCTs demonstrated excellent performance for dosimetric
and IGRT endpoints, offering potential use in high precision brain cancer therapy.
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1 | INTRODUCTION
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treatment. Eight patients underwent surgical resection before presenting for radiation therapy. All CT simulations were performed on

Magnetic resonance imaging (MRI) provides superior soft tissue con-

a Brilliance Big Bore CT scanner (Philips Health Care, Cleveland, OH)

trast than computed tomography (CT), the gold standard image modal-

with 120 kVp. Per our clinical practice, SRS patients were acquired

ity used for treatment planning in radiotherapy. The incorporation of

with a high resolution CT protocol (in‐plane resolution of

MRI as an adjunct to CT signiﬁcantly reduces inter/intraobserver varia-

0.88 × 0.88 mm2, 1 mm slice thickness) while conventionally frac-

tions in structure delineation.1 As a complimentary modality, the MRI

tionated brain cases were acquired with an in‐plane resolution of

is registered to simulation CT (simCT) to transfer MRI delineated struc-

1.17 × 1.17 mm2, 2 mm slice thickness. Patients were immobilized

tures for treatment planning. However, this multimodality registration

using a thermoplastic head mask during CT simulation, onboard

may introduce up to ~ 2 mm of systematic error in the head region.2–4

imaging acquisition, and treatments. MR scans were acquired with a

In an effort to eliminate multimodality image registration uncertainty

1.0T Panorama High Field Open MR Simulator (Philips Medical Sys-

and improve clinical efﬁciency, MR‐only treatment planning has

tems, Best, the Netherlands) without any immobilization devices in

emerged as a viable treatment option for many disease sites.5–7

order to accommodate the eight‐channel head coil. Postgadolinium

Yet, implementing MR‐only treatment planning presents several

T1‐weighted images were acquired for each patient with a voxel size

challenges including that MRI does not provide electron density

of 0.90 × 0.90 × 1.25 mm3. On‐board cone beam CT (CBCT) and

information required for accurate dose calculation. In the brain, sev-

kilovoltage (kV) planar images were acquired on three different linear

eral synthetic CT (synCT) generation methods from MRI data have

accelerators: Edge (nine patients), Novalis TX (two patients), and

been developed including bulk density assignments, atlas‐based,

TrueBeam (one patient) with CBCT slice thickness ranging from 1 to

voxel‐based, and machine learning‐based methods.8–14 Recently,

2.5 mm (0.5 to 0.65 mm pixel size). On‐board kV images were

deep learning has achieved superior accuracy in synCT generation

acquired with pixel size of 0.2 × 0.2 mm2 and were exported along

than other approaches.8–12 Wang et al.15 reported that synCT gener-

with digitally reconstructed radiographs (DRRs) from the Eclipse®

ated from a path‐based random forest method achieved less than

Treatment Planning System (TPS) (Varian Medical Systems, Palo Alto,

0.6% dose difference in target DVH metrics and a 99% average

CA, USA) using an integrated DICOM ﬁlter (Image Browser V15.5)

gamma passing rate (3%/3mm) in brain stereotactic radiosurgery

for subsequent registration.

16

(SRS) treatments. Kazemifar et al.

assessed the dosimetric accuracy

of generative adversarial networks (GANs) generated synCT in brain
radiotherapy and found <1% dose difference in dose–volume his-

2.B | Synthetic CT Generation and Preprocessing

togram (DVH) endpoints. Despite the existing studies on dosimetric

The synCT images were generated using a previously developed

performance, very few studies have assessed the performance of

GAN deep learning model.12 The GAN model trains two competing

17

and

networks simultaneously: (a) an encoder–decoder architecture called

Morris et al.18 found that synCTs generated using voxel‐based

the generator, which tries to generate the synCTs from the input

weighted summation achieved similar performance for whole and

MR images (b) and a discriminator which classiﬁes the generated

partial brain IGRT, respectively. However, the synCT method

synCTs as real or synthetic.19 The generator’s architecture includes

employed required multiple MR datasets to generate synCT images

nine residual blocks, where the discriminator is a CNN with ﬁve con-

that may have introduced other potential coregistration errors and

volutional layers. As outlined in detail in the original developmental

did not implement deep learning. We recently developed and vali-

work, the GAN model was validated using a ﬁvefold cross‐validation

dated a GAN model that generates brain synCTs from a single MRI

technique. A detailed comparison of GAN synCT and simpliﬁed CNN

input in ~6 s, yielding excellent agreement to the corresponding

highlighted that our GAN reduced the mean absolute error and bet-

CT.12 This work aims to further evaluate the dosimetric and IGRT

ter preserved details than CNN.12

synCT for image‐guided radiation therapy (IGRT). Price et al.

performance of GAN generated synCT (GAN‐synCT) in the brain and

To ensure equivalent dosimetric and IGRT comparisons were

compare its performance for clinical use including conventional brain

conducted between the simCT reference and synCT, all synCTs were

radiotherapy, cranial SRS, planar IGRT, and volumetric IGRT.

sampled to the CT simulation grid resolution for each patient case
for ﬁnal analysis. All synCT images were then rigidly registered to

2 | METHODS
2.A | Data acquisition

the corresponding simCT images using Statistical Parametric Mapping software20 (SPM12, Functional Imaging Laboratory, The Wellcome Trust Centre for NeuroImaging, University College London).
The coregistered synCT images were converted into DICOM and

A cohort of 12 brain cancer patients treated on Edge, Novalis TX, or

imported into the Eclipse TPS using an in‐house MATLAB (Math-

TrueBeam linear accelerator platforms (Varian Medical Systems, Palo

works, Natick, MA) code. The clinical structures delineated on simCT

Alto, CA, USA) were retrospectively evaluated as part of an Institu-

images were transferred to the coregistered synCT images. To

tional review board approved study. Six patients underwent cranial

ensure the same dose calculation volumes between each simCT/

SRS and six underwent conventional brain radiotherapy (with more

synCT plan pair, the external body (i.e., structure used to deﬁne dose

than ﬁve fractions), among which three patients had a boost

calculation volume) was deﬁned by the synCT dataset.
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were compared. Two‐dimensional (2D) rigid registrations between

2.C | Treatment planning

on‐board kV images and DRR (n = 7) were completed using Elastix

A total of 15 clinically treated treatment plans (12 primary plans and

(University Medical Center Utrecht, Utrecht, Netherlands) via an in‐

3 boost plans) generated on simCT data using either volumetric

house MATLAB tool previously described.17,18 Normalized mutual

modulated arc therapy (VMAT, n = 13) or dynamic conformal arc

information (NMI) was used as the voxel‐based similarity metric26 to

(DCA, n = 2) were copied onto synCT images. Dose was recalculated

determine the translations in the registrations of both the anterior–

for both simCT (with new external body boundary) and synCT plans

posterior and lateral DRR images to their corresponding kV images.

with ﬁxed monitor units and the same dose calculation grid volumes
using the Eclipse Anisotropic Analytical Algorithm (AAA, v.11).

2.F | Analysis for statistical comparisons
To assess the agreement between the simCT and synCT measure-

2.D | Dosimetric performance evaluation

ments, intraclass correlation coefﬁcients (ICC)27 were computed for

Dose distributions calculated on synCT images were compared

DVH metrics, CBCT‐CT, and kV‐DRR registration. To account for the

against the simCT dose distributions via three methods: (a) point

correlations among multiple measurements from the same patient

dose discrepancy in terms of mean error (ME) with standard devia-

(e.g., primary and boost plan and multiple CBCT‐CT registrations),

tion (SD) evaluated for clinical DVH metrics, (b) plan quality change

generalized estimating equations (GEE) methods were used to com-

as indicated by gradient index (GI) and conformity index (CI), and (c)

pare simCT and synCT agreement for the outcomes of DVH metrics

2D gamma analysis21 conducted in the axial plane evaluated at the

and CBCT‐CT registrations. The standard errors address the correla-

isocenter location for the synCT and simCT based plans in a manner

tions among multiple measurements from the same patient. Addi-

similar to our standard clinical evaluation.

tionally, paired t‐tests were done to compare the simCT and synCT

The evaluated DVH metrics were deﬁned in Quantitative Analy-

outcomes of DVH metrics, kV‐DRR, and CBCT‐CT registration. Dif-

ses of Normal Tissue Effects in the Clinic (QUANTEC)22 and AAPM

ferences with the p value less than 0.05 considered signiﬁcant. All

Task Group No. 101 Report,23 including D99% and D95% for the tar-

analyses were done using SAS version 9.4 (Cary, NC).

get, D0.02cc for optic pathways, D0.05cc for brainstem, and D0.035cc
for both target and organs at risk (OARs). D99% and D95% represent
the doses delivered to 99% and 95% of the planning target volume
(PTV), and D0.035cc, as a representation of maximum dose, is the
dose to 0.035cc of a structure’s volume. GI, deﬁned as the ratio of
the volume of half the prescription isodose to the volume of the

3 | RESULTS
3.A | Dosimetric performance
3.A.1 | DVH metrics and plan quality

prescription isodose, describes how fast the dose falls off outside of

Table 1 summarizes key DVH metric results. Among 15 tested plan

the target.24 CI is the ratio of 100% isodose volume to the volume

pairs, the mean difference (MD) was ≤0.10 ± 0.04 Gy for the target

of the PTV, indicating how well the prescription dose conformed to

D95% and ≤0.13 ± 0.04 Gy for OARs. While some statistically signiﬁ-

25

cant deviations were observed, the overall differences were deemed

the target.

Gamma analysis at 1%/1 mm and 2%/2 mm (dose difference/dis-

to not be clinically signiﬁcant (i.e., low dose difference (<0.05 Gy)).

tance to agreement) was conducted using a low‐dose threshold of

The ICCs for evaluated DVH metrics were above 0.99, indicating

10% of the maximum dose in simCT plan using in‐house software.

excellent agreement between simCT and synCT plans. Across the

For cases with tumor volumes >100cc, a 30 × 30 cm dose plane

entire cohort, close concordance in the GI for the synCT plans

was used to evaluate the global dose distribution. For the remaining

(3.88 ± 1.77, Range: 2.35 to 9.74) as compared to that of the simCT

cases with small tumor volumes, a 15 × 15 cm2 dose plane was

plans (3.76 ± 1.69, Range: 2.26 to 9.40) was observed. The maxi-

exported to yield higher resolution.

mum GIs of 9.74 and 9.40 for the synCT and simCT plans, respec-

2

tively, occurred for a patient who had a simultaneous integrated

2.E | IGRT performance evaluation

boost with two separate target volumes treated with fractionated
SRS to 32 Gy (Case SRS3 in Fig. 1). Similarly, the average CI was

To assess synCT performance for IGRT, ofﬂine rigid registrations

1.12 ± 0.40 (Range: 0.49 to 2.26) and 1.14 ± 0.40 (Range: 0.59 to

were performed between daily on‐board images and both simCT and

2.33) for synCT and simCT plans for the entire cohort, respectively.

synCT reference images. CBCTs were rigidly registered to synCT

No signiﬁcant differences were observed in GI and CI between

images using the Image Registration Workspace in Eclipse using six

synCT plans and simCT plans (P > 0.05).

degrees of freedom (three translational and three rotational). The
registration was then compared for equivalence to the corresponding
CBCT‐simCT registrations to quantify in registration discrepancy. For

3.A.2 | Gamma analysis

patients with more than ﬁve CBCTs acquired during the treatment

When comparing the synCT and simCT doses through an axial plane at

course, the ﬁrst ﬁve CBCTs were chosen for evaluation. A total of

isocenter, the gamma passing rates (γ < 1.0) averaged over 15 plans

43 independent CBCT‐synCT and CBCT‐simCT registration pairs

were 99.9 ± 0.2% (range, 99.4%–100%) at 2%/2 mm and 99.0 ± 1.5%

LIU

|

ET AL.

T A B L E 1 Differences in dosimetric endpoints for the planning
target volume (PTV) and organs at risk among 15 simCT/synCT plan
pairs in 12 unique patients. Mean difference (MD) and standard
error (SE) reported.
Dose Difference (Gy)

MD ± SE

[Min, Max]

P‐value

311

3.B | IGRT performance
The MDs between the CBCT‐synCT/simCT registrations and kV‐
synCT DRR/simCT DRR registrations are summarized in Table 2. The
population

averaged

MD

in

CBCT‐synCT

registrations

were

<0.2 mm and 0.1 degree different from simCT‐based registrations.

PTV
D95%
D99%
D0.035

cc

0.10 ± 0.04

[−0.15, 0.35]

0.010*

The largest differences were observed for synCT images associated

0.05 ± 0.04

[−0.19, 0.29]

0.165

with Con4 and Con4 Boost, with a maximum registration difference

0.05 ± 0.04

[−0.30, 0.49]

0.277

of 2.3 mm in S/I direction as compared simCT‐based registration.
The MDs between kV‐synCT DRR/simCT DRR registration pairs

Brainstem
D0.035cc

0.13 ± 0.04

[−0.01, 0.43]

0.001*

D0.5

0.09 ± 0.03

[0.00, 0.35]

0.001*

cc

were within 0.5 mm with no statistically signiﬁcant differences
observed (P > 0.05). The largest difference was again noticed in registrations related to synCT associated with Con4 and Con4 Boost:

Chiasm

with registration difference of −1.62, −1.48, and 0.73 mm in R/L,

D0.035cc

0.08 ± 0.03

[−0.01, 0.34]

0.003*

D0.2

0.00 ± 0.08

[−1.06, 0.35]

0.966

0.09 ± 0.04

[−0.01, 0.41]

0.007*

0.06 ± 0.03

[−0.13, 0.36]

0.020*

0.09 ± 0.05

[−0.01, 0.79]

0.070

with a small target (0.91 cc) seated in the middle of the brain. Note

0.06 ± 0.03

[0.00, 0.40]

0.010*

that the synCT maintained the same ﬁne anatomical details as the

cc

A/P, and S/Is/i directions respectively.

Left Optic Nerve
D0.035
D0.2

cc

cc

Right Optic Nerve
D0.035
D0.2

cc

cc

3.C | Case studies
Figure 2 summarizes dosimetric results for a typical SRS case (SRS1)
and the case with the worst gamma results (SRS2). SRS1 presented

*signiﬁcant at P < 0.05.

simCT with the presence of air cavities and bone. Figures 2(c) and 2
(d) demonstrate excellent dosimetric agreement in the target region

(range, 94.8%–100%) at 1%/1 mm, as summarized in Fig. 1. Gamma
analysis at 2%/2 mm criteria revealed similar passing rates between
the SRS and conventional cases (100 ± 0.0% and 99.9 ± 0.2%, respectively). For 1%/1mm criteria, SRS yielded 99.5 ± 0.7% and conventional 98.7 ± 1.8% passing rates. The lowest gamma passing rates for
the population occurred for conventional case 4 (99.6% at 2%/2mm
and 94.8% at 1%/1mm) with similar performance for the corresponding boost plan (Con4 Boost), as shown in Fig. 1.

between dose calculations as shown by the dose proﬁles from the
synCT and simCT. The gamma criteria passing rates were 100% at
both gamma criteria as seen in Figs. 2(e)–2(g). As a comparison,
SRS2 had a larger metastatic lesion (17.2 cc) situated in close proximity to the skull affected by a region of surgical resection. Despite
the synCT not representing the entire discontinuity in the skull,
Fig. 2, part (e), for SRS2 showed overall good agreement between
simCT and synCT dose proﬁles. As the worst‐case scenario in SRS
cases, SRS2 achieved 98.3% and 100% gamma passing rates at 1%/

F I G . 1 . Gamma passing rates at 1%/1 mm and 2%/2 mm comparing dose distributions of synthetic CT (synCT) plan and of simulation CT
(simCT) plan. Abbreviations: SRS = stereotactic radiosurgery; Con = primary plan of conventional brain radiotherapy; Con Boost = boost plan of
conventional brain radiotherapy.
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T A B L E 2 Differences of volumetric cone beam computed tomography (CBCT‐synCT/simCT, 43 observations in 12 subjects) and planar
(kilovoltage (kV)‐synCT DRR/simCT DRR, 7 observations in 7 subjects) image registrations for image‐guided radiation therapy evaluation.
Registration
CBCT‐CT
MD ± SE
[Min, Max]
P‐value

Translational Difference (mm)

Rotational Difference(°)

R/L

A/P

S/I

Pitch

Yaw

Roll

−0.04 ± 0.06
[−0.40,0.70]

−0.10 ± 0.06
[−1.10, 0.30]

−0.13 ± 0.16
[−2.30,1.60]

0.01 ± 0.04
[−0.40, 0.70]

0.05 ± 0.03
[−0.50, 0.50]

0.04 ± 0.03
[−0.40, 0.50]

0.69

0.15

0.21

0.47

0.06

0.39

kV‐DRR

R/L

A/P

S/I

Transverse Plane

Sagittal Plane

MD ± SE
[Min, Max]

−0.36 ± 0.30
[−1.62,0.91]

−0.20 ± 0.24
[−1.48,0.66]

−0.32 ± 0.17
[−0.11,0.88]

0.000 ± 0.002
[−0.004, 0.002]

0.000 ± 0.003
[−0.004, 0.006]

0.78

0.77

p‐value

0.28

0.45

0.11

Abbreviations: A/P, Anterior/Posterior; MD, mean difference; R/L, Right/Left; S/I, Superior/Inferior; SE, standard error.

1 mm and 2%/2 mm, respectively. IGRT evaluation yielded results

deviation among all tested image pairs, with translational differences

similar to the population mean for both SRS1 and SRS2 cases.

of −1.62, −1.48, and 0.73 mm at R/L, A/P, and S/I directions, respec-

Figure 3 summarizes key results for the conventional radiation

tively.

therapy cohort for a typical patient and a patient with lower dosimetric agreement between synCT and simCT. As shown in Fig. 3,
Con5 consisted of a patient with recurrent cerebral meninges seated

4 | DISCUSSION

in the pituitary fossa abutting the anterior clinoid and treated to a
total dose of 54 Gy using three DCAs. Although the synCT predicted

This work sought to evaluate the dosimetric accuracy and IGRT per-

decreased density in the bony region abutting the lesion (i.e., the

formance of GAN‐synCTs generated for the brain for different clini-

tuberculum sellae), the dosimetric comparison revealed excellent

cal scenarios. Overall, results showed excellent agreement between

agreement between synCT and simCT plans, as shown in the dose

synCT and simCT with DVH MEs <0.2 Gy. While 7 of 11 DVH met-

color wash and line proﬁles with 100% gamma passing rates at both

rics had statistically signiﬁcant differences for the population, differ-

1%/1 mm and 2%/2 mm criteria.

ences were not considered clinically signiﬁcant due to the low dose

By contrast, Con4 had a larger tumor (372.3 cc) that was situ-

difference (<0.05 Gy) when compared to prescription dose of at

ated in close proximity to the skull and had undergone a surgical

least 18 Gy. Generally speaking, excellent agreement in dose planes

resection. Compared with the corresponding simCT, the synCT

at the isocenter was observed between datasets (mean gamma pass-

showed an increased skull thickness, especially near the tumor vol-

ing rates were 99.9% and 99.0% at 2%/2 mm and 1%/1 mm, respec-

ume. Nevertheless, the dose proﬁle indicated good agreement across

tively), which surpassed the typical clinical criteria of 95% at 3%/

the target. Figures 3(f) and 3(g) for Con4 showed that the regions

3 mm.28 Our GAN‐synCT showed comparable results for accurate

failing gamma criteria were along the periphery of the head and near

dose calculation to previously reported work by our group. Zheng

the skull region that was impacted by surgical resection with gamma

et al. reported a mean gamma passing rate of 99.4% at 2%/2 mm for

passing rates of 94.8% and 99.6% at 1%/1 mm and 2%/2 mm,

brain synCTs generated using a hybrid magnitude and phase MRI pro-

respectively. For the same patient (Con4), the boost plan using the

cessing pipeline that required several input images for synCT genera-

same synCT image yielded gamma passing rates of 96.0% at 1%/

tion.14 Another study evaluating brain synCT generated using dilated

1 mm and 99.4% at 2%/2 mm. Despite the lowest gamma passing

CNNs reported less than 1.5% difference in target dose as compared

rates observed in this case, Fig. 4 illustrates that the DVHs were in

to the corresponding CT and yielded a mean gamma passing rate of

good agreement for both Con4 (46 Gy in 2 Gy/fx) and Con4 Boost

98.8% at 1%/1 mm.29 Wang et al.15 showed that brain synCTs gener-

(14 Gy in 2 Gy/fx). Minimal differences between simCT and synCT

ated from a path‐based random forest method in 14 brain SRS cases

DVH curves were also reﬂected by dose differences for clinical DVH

achieved less than 0.6% dose difference in target DVH metrics and a

metrics (<0.3 Gy for targets (D95%, D99%, and D0.035

and brain-

99% average gamma passing rate at 3%/3 mm. Our work outperformed

cc), and <0.6 Gy for optic pathways (D0.2cc

a more recent investigation on GAN‐based brain synCT that reported

cc)). IGRT evaluation of this case showed that the registra-

less than 1% dose difference for targets and OARs and gamma passing

tion differences were larger than the population average values. The

rates of 98.7% and 93.6% at 2%/2mm and 1%/1mm, respectively.29

CBCT‐simCT/synCT comparison revealed translational differences of

Our work adds to the literature by also considering IGRT performance

0, −0.34, and −1.34 mm in the right/left (R/L), anterior/posterior

for our cohort, as well as quantifying the dosimetric impact.

stem (D0.5cc and D0.035
and D0.035

cc)

(A/P), and superior/inferior (S/I) directions, and rotational differences

IGRT evaluation showed that differences between synCT‐based

of −0.14, 0.14, and −0.08 degrees for pitch, yaw, and roll, respec-

and simCT‐based registrations were minimal. The MDs between vol-

tively. This synCT also yielded the largest kV‐DRR registration

umetric registration pairs were <0.2 mm and <0.1°. The largest
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(a)

(b)

(e)

(c)

(d)

(f)

(a)

(b)

(e)

(c)

(d)

(f)
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(g)

(g)

F I G . 2 . Two representative stereotactic radiosurgery (SRS) cases: SRS1 and SRS2. (a) and (b) demonstrate axial views of the simulation
(simCT) and synthetic (synCT) at isocenter with the planning target volume (PTV) delineated; (c) and (d) show the corresponding dose
distributions at the same axial plane; (e) illustrates the dose proﬁles along the line drawn on (c) through the PTV; (f) and (g) display the gamma
map analyzed at 1%/1 mm and 2%/2 mm criteria, respectively.

discrepancy occurred for CBCT‐guided conventional cases in the S/I

0.0 ± 0.5 mm, and 0.1 ± 0.3 mm in S/I, L/R, and A/P directions,

direction, likely due to the 2.5 mm slice thickness that may lead to

respectively).17

increased registration uncertainties. Similarly, Gupta et al.30 reported

One limitation of present work is the small cohort of patient

MEs of −0.1, −0.1, and −0.2 mm in the A/P, R/L, and S/I directions,

(12 patients, 15 plans) from a single institution and MRI scanner.

respectively, for synCTs generated using a deep learning U‐Net

Nevertheless, a variety of patient conditions and plans, including

architecture trained on sagittal T1‐weighted MRI datasets. For

state of the art DCA and SRS, were considered to test the GAN‐

orthogonal planar registrations, GAN‐synCT achieved <0.4 mm and

synCT performance over a range of settings. GAN‐synCT main-

0.01 degree differences as compared to simCT which were compara-

tained most of the details in simCT although some differences

ble to those observed by Price et al. evaluating synCTs generated

were noted in regions of the skull that contained underestimates

through a voxel‐based weighted summation method (0.4 ± 0.5 mm,

of the discontinuities along

air‐tissue interfaces. The worst
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(d)

(f)

(a)
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(c)

(d)
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(g)

(g)

F I G . 3 . A typical conventional case (Con5) and the worst‐case scenario (Con4). (a) and (b) demonstrate axial views of the simulation (simCT)
and synthetic (synCT) at isocenter with the planning target volume (PTV) delineated; (c) and (d) show the corresponding dose distributions at
the same axial plane; (e) illustrates the dose proﬁles along the line drawn on (c) through the PTV; (f) and (g) display the gamma map analyzed
at 1%/1 mm and 2%/2 mm criteria, respectively.

performing case in the cohort highlighted in Figs. 3(f) and 3(g) for

generated synCTs using deep CNNs and observed larger errors at

Con4 suggested that the regions failing gamma criteria occurred

the bone and air boundary due to high intensity gradients and

near the periphery of the head. Dose distributions along peripheral

imperfect alignment between MR and simCT. Paradis et al.31

regions are susceptible to partial volume effect due to different

showed larger dose discrepancy caused by differences in the

resolutions of simCT and synCT. Other potential sources of uncer-

regions of close proximity of air cavities between simCT and

tainty are the presence of immobilization devices in simCT but

synCT generated from multiple MR images using probabilistic

not in the MR‐SIM acquisition used to generate synCTs as well as

voxel classiﬁcation. Although in this study, the resulting dose dif-

any residual coregistration uncertainties used in the dosimetric

ferences were found to be clinically insigniﬁcant, an ideal synCT

evaluation. Previous studies reported similar challenges in accurate

generation would be more robust and address these discontinu-

synCT generation at air‐bone and air‐tissue interfaces.6,31 Han32

ities.
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F I G . 4 . Dose volume histogram (DVH)
comparison for conventional brain case 4
(Con4) that yielded the lowest gamma
passing rates at isocenter. Nevertheless,
minimal differences in the DVHs for both
the primary (a) and boost (b) plans were
observed. The solid curve represents
simulation CT plan and the dotted curve
represents synthetic CT plan.
Another source of uncertainty was observed near skull regions

Future studies can fully evaluate potential uncertainties and failure

that are impacted by surgical resection where the synCT tended to

modes via effects analysis as we have previously conducted in pelvis

overestimate the skull thickness in the surgical cavity region as com-

MR‐only planning.34

pared to simCT such as in Fig. 3 (Con4). This led to increased discrepancies in volumetric IGRT performance with a maximum
registration difference of 2.3 mm in S/I direction as compared

5 | CONCLUSION

simCT‐based registration. While potential dose disagreement may be
possible due to this performance if the tumor was in close proximity

GAN‐synCT was evaluated in terms of dosimetric and IGRT accuracy

to this region, no clinically signiﬁcant dose deviations in plan quality

for brain radiotherapy. Results showed comparable performance of

or IGRT performance were observed in this study. However, this

synCT under multiple clinical settings as compared to standard of

suggests that caution needs to be exercised in patients with atypical

care simCT. This work illustrates the feasibility of clinical implemen-

anatomy that may exhibit larger errors than this cohort. These dis-

tation of GAN‐synCT in MR‐only radiotherapy for brain cancer.

crepancies can be addressed by visual evaluation during the training
phase of the deep learning algorithm and by integrating additional
atypical anatomy into the training set. An area of emerging interest
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